Forecast Order
On ClinPhone Pro: one-click forecasting and shipment prediction, designed to anticipate supply needs before a shortage interrupts treatment.
Get the right kit to the right site for every participant, with less waste and fewer surprises along the way.
We can bring clinical supply specialists, simulation and forecasting, as well as our ClinPhone Pro RTSM platform to your study. Engage once, at a single decision, or across the whole study lifecycle.
Most supply and randomization decisions are still made on spreadsheets, static assumptions and one-shot forecasts. That works until the trial stops behaving the way the plan predicted, and by then the options are narrower and the fixes cost time.
ClinPhone Pro executes, the intelligence engine predicts and models, and our specialists turn the outputs into decisions and IRT configuration changes.
Layer 1 · Execution on ClinPhone Pro
On ClinPhone Pro: one-click forecasting and shipment prediction, designed to anticipate supply needs before a shortage interrupts treatment.
See inventory, lots, expiry dates and resupply strategies in one place, with accountability, reconciliation, returns and destruction workflows.
Depot-to-depot, depot-to-site, site-to-site and direct-to-patient shipments, with forecasting, approvals and dispatch management. For direct-to-patient, the courier or sponsor holds participant address details, in line with GDPR.
Update inventory settings and operational parameters yourself, without raising a change request.
Layer 2 · Predictive intelligence
Simulation, forecasting and optimization, run against your protocol, your IRT and your live study data.
We turn protocol requirements into an executable supply design, with feasibility and risk reviews before the build starts.
Test recruitment, dosing, amendments and country expansion before you commit, with quantified trade-offs across cost, waste, stock-out risk and service level.
We validate and re-tune triggers, buffers, stock levels and supply schemes at build, then re-simulate as the study moves.
Layer 3 · Expert advisory
Randomization and supply specialists turning model outputs into decisions your team can act on.
Strategy design, stratification planning, adaptive designs, list generation, and IRT readiness review.
Review of first randomization, first dispensation, resupply and expiry events, with ongoing monitoring of stock-out and expiry risk.
An independent review of a supply decision, or expert help when an unexpected supply event puts your timelines at risk.
Short, scenario-based sessions that help your study team make better IRT and supply decisions. Today they focus on medication management: supply schemes and expiry settings in your IRT.
Take the full study lifecycle, or take one decision. Both are normal.
Initial supply strategy modeled at participant and site level. The impact of design and protocol choices is simulated before commitments are made, and sourcing decisions are backed by scenario evidence.
Trigger, resupply and lookahead settings validated by simulation rather than assumption, and planning assumptions stress-tested against the configuration that will actually run.
Batch sizing and order timing re-forecast as recruitment behaves. Mid-study changes and depot additions are modeled before they are committed, with continuous re-forecasting where recruitment is volatile.
Study review, protocol adherence checks, issue investigation and change request support.
Supply strategy, randomization and the platform that runs them are one connected system. Here is how the pieces fit together.
Our RTSM platform. Your supply strategy becomes configuration here.
Explore ClinPhone ProReady-to-deploy RTSM on proven configurations, for studies that do not need heavy customization.
Explore ClinPhone Pro CoreThe same team covers randomization strategy, stratification planning, adaptive designs and IRT readiness reviews.
Explore RandomizationEverything between the protocol and the kit a participant receives: supply strategy, forecasting, inventory, shipments, expiry, and the IRT settings that drive resupply. We support each of these through advisory work, on ClinPhone Pro, or both.
No. We advise on studies running on other IRT systems. On ClinPhone Pro, we can also act on the configuration directly.
As early as trial concept, while protocol requirements are still being shaped into a supply design. Mid-study support is a large part of what we do, but early involvement gives you more options.
Yes. Modular support is designed for one decision, such as first batch sizing, a supply scheme review, or a second opinion on a resupply strategy.
It models how your supply plan behaves under different assumptions about recruitment, dosing, sites and countries, so you can compare options before manufacturing or configuration decisions are locked.
Complex designs are the core of it: adaptive trials, oncology, radiopharmaceuticals, platform trials, gene and cell therapies, and personalized medicine, where manufacturing capacity, dosing calculations and logistics constraints interact.
Yes. We run short, scenario-based sessions for study teams, currently focused on medication management: how supply schemes and expiry settings in your IRT shape what reaches each site. Further topics are in development.
Tell us where your study is and what you are about to commit to. Our specialists will tell you what we would test first.